SCHEMBL19786404

SCHEMBL19786404

Cc1ccc2[nH]nc(Cc3cc(C)c(C(C)(C)C)c4c(C#N)n[nH]c34)c2c1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20132921 0.84 ROCK2 (0.33) —
SCHEMBL19104234 0.80 ERBB2 (0.34) —
SCHEMBL19104231 0.71 MAPK1 (0.32) —
SCHEMBL19104288 0.70 MAP2K4 (0.35) —
SCHEMBL23879998 0.69 ROCK1 (0.34) —
SCHEMBL22328054 0.68 FFAR1 (0.33) —
SCHEMBL19115758 0.67 MAP2K1 (0.38) —
SCHEMBL22924136 0.67 NR3C2 (0.37) —
SCHEMBL17833922 0.65 MAPK1 (0.35) —
SCHEMBL22328045 0.63 ADRA2A (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180015087-A1 CONJUGATES OF CEREBLON BINDING COMPOUNDS AND G12C MUTANT KRAS, HRAS OR NRAS PROTEIN MODULATING COMPOUNDS AND METHODS OF USE THEREOF ARAXES PHARMA LLC 2018-01-18 — — US disclosed
Send feedback